Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
- Status
- RECRUITING
- Phase
- NA
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1